AIM
HAE icon

Aigen Investment Management’s Haemonetics HAE Stock Holding History

Aigen Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,959
Closed -$479K – 845
2024
Q3 		$479K Buy
+5,959
New +$481K 0.09% 337
2022
Q1 		– Sell
-7,600
Closed -$397K – 764
2021
Q4 		$397K Buy
+7,600
New +$463K 0.02% 700
2020
Q2 		– Sell
-558
Closed -$56K – 999
2020
Q1 		$56K Sell
558
-30,699
-98% -$3.33M 0.01% 965
2019
Q4 		$3.59M Buy
+31,257
New +$3.78M 0.59% 24

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Aigen Investment Management's HAE Position: Q4 2024 in Review

Aigen Investment Management sold out of Haemonetics (HAE) in Q4 2024, closing a stake of 5,959 shares — an estimated $479K sold.

Aigen Investment Management first reported a position in HAE in Q4 2019 and held it in 4 quarters. The position peaked at $3.59M in Q4 2019. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.

  • Aigen Investment Management reported no remaining Haemonetics position as of Q4 2024 after selling out during the quarter.
  • Aigen Investment Management sold 5,959 Haemonetics shares in Q4 2024, an estimated $479K.
  • Aigen Investment Management first reported a position in Haemonetics in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Haemonetics position peaked at $3.59M in Q4 2019.
  • 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.

Based on Aigen Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.